About NAGASE
Basic Principle
CEO Message
Management Policy and Plan
Corporate Profile
Organization
Board of Directors & Executive Officers
NAGASE Group
History of NAGASE
News
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Business Introduction
Performance Chemicals Department
Speciality Chemicals Department
Polymer Global Account Department
Electronics Department
Advanced Functional Materials Department
Mobility Solutions Department
Life & Healthcare Products Department
Nagase Bio-Innovation Center
Nagase Application Workshop
Future Co-creation Office
NAGASE Biotech Office
Investor Relations
IR News 2026
Investor Relations Library
Shareholder Information
Individual Investors
Financial Information
Latest IR Materials
Package Download (zip:23.2MB)
Consolidated Financial Statements for the Nine Months Ended December 31, 2025(1.3MB)
FY2025 Third Quarter Financial Briefing(2.7MB)
Consolidated Financial Statements for the Six Months Ended September 30, 2025(1.5MB)
FY2025 Second Quarter Financial Briefing(2.7MB)
Corporate Governance Report(867KB)
Integrated Report/Annual Report 2025(17.4MB)
Sustainability
Sustainability in the NAGASE Group
Top Message
Integrated Report/Annual Report
Environment
Social
Governance
Sustainability Data Sheet
Social Contributions Activities
Athlete Support
External evaluation and Initiatives
Content Index
About the Sustainability Website
Contact Us
NAGASE Group
Website
NAGASE Group Website

HOME
Investor Relations
IR Newsreleases

IR News：2026

Select Year :

DisclosureFebruary 17, 2026
Consolidated Financial Statements for the Nine Months Ended December 31, 2025 (pdf:1 MB)
DisclosureFebruary 05, 2026
Notice Regarding Establishment of a Subsidiary (Change in Subsidiary) (pdf:256 KB)
DisclosureFebruary 05, 2026
Notice Regarding Repurchase of Own Shares (pdf:139 KB)
DisclosureFebruary 05, 2026
Notice Regarding Revision to Dividend Forecasts (Dividend Increase) (pdf:141 KB)
DisclosureFebruary 05, 2026
FY2025 Third Quarter Financial Briefing (pdf:3 MB)
DisclosureFebruary 05, 2026
[Summary]Consolidated Financial Statements for the Nine Months Ended December 31, 2025 (pdf:1 MB)
DisclosureJanuary 29, 2026
Notice Regarding Changes of Directors, Audit & Supervisory Board Members and Executive Officers (pdf:182 KB)
DisclosureJanuary 20, 2026
Notice Regarding the Status and Completion of Repurchase of Own Shares (pdf:74 KB)
DisclosureJanuary 05, 2026
Notice Regarding the Status of Repurchase of Own Shares (pdf:73 KB)